Why the study?
Do lifestyle modifications and pharmacologic agents (anti-diabetics, anti-hypertensives) prevent the development of type 2 diabetes in high-risk individuals?
Population
High-risk individuals with pre-diabetic conditions such as metabolic syndrome, hypertension, impaired…
Design
Review
Authors
Loading...
May support preventive strategies in high-risk patients; leaves open need for confirmatory randomized trials.
Do lifestyle modifications and pharmacologic agents (anti-diabetics, anti-hypertensives) prevent the development of type 2 diabetes in high-risk individuals?
Lifestyle modifications and certain pharmacologic therapies (anti-diabetics, ACEi/ARBs) may represent effective preventive strategies for type 2 diabetes in high-risk patients.
Abuissa et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: